Egg Powder Veterinary Grade API is a spray-dried whole-egg product derived from controlled laying flocks and is supplied as a pale-yellow to orange amorphous powder with characteristic albumen odour. The product is specified for solid, semi-solid, and solution-based veterinary dosage forms—tablets, capsules, powders, granules, premix, and solutions—provided that the relevant downstream fractionation or hydrolysis is applied before injection. The powder is standardised for protein, lipid, moisture, water activity, particle size, microbiological clearance, and, when ordered, endotoxin content. No dedicated compendial monograph exists for whole-egg powder; therefore the material is controlled by a supplier specification supported by Ph. Eur. 2.6.12, Ph. Eur. 2.6.14, ISO 6579-1:2017, ISO 13320:2020, ISO 18787:2017, AOAC 925.30, AOAC 925.32, and USP <616>. Typical composition is 43–47 g/100 g protein by Kjeldahl nitrogen with conversion factor 6.25, 35–40 g/100 g fat, ≤ 4.0 g/100 g moisture, and 0.20–0.35 water activity. The loose bulk density is 0.30–0.45 g/cm³, and the tapped bulk density is 0.45–0.65 g/cm³. Model designations are manufacturer-specific; the relevant physical grade for tableting and capsule filling is conventionally identified by a D90 suffix, with target D90 ≤ 90 µm for high-uniformity blends or ≤ 150 µm for premix applications.

The manufacturing route begins with low-temperature, continuous plate or tubular pasteurization followed by high-pressure nozzle atomization in a spray dryer. Published supplier data typically place inlet air temperature at 160–180 °C and outlet air temperature at 70–85 °C; residence time in the drying chamber is kept below 30 s to limit irreversible denaturation of ovalbumin and lysozyme. The dried fraction is then sieved through stainless-steel vibratory sieves and blended into homogeneous lots. Because egg proteins are heat-coagulable, outlet temperature is the controlling parameter rather than inlet temperature; excursions above 85 °C at high moisture content can produce browned particles, reduced solubility, and increased acid-insoluble matter. Spray-dried egg powder is therefore not considered interchangeable with lyophilized egg albumen or mechanically dried egg flakes when reconstitution or binding in wet granulation is required. Unlike gelatin, which can be reversibly gelled, the heat-set protein network of egg powder is irreversible after denaturation, and unlike purely synthetic binders such as povidone or hypromellose, the powder contributes both protein and phospholipid lipid fractions to the dosage form.

Why Spray-Dried Egg Powder Is Not Interchangeable with Feed-Grade Egg Solids

The separation between veterinary-grade API and feed-grade egg solids is defined by microbiological specification, residue control, and documentation. Veterinary-grade material is produced under API GMP conditions and is tested for total aerobic microbial count against Ph. Eur. 2.6.12 with a boundary of ≤ 10³ CFU/g, while feed-grade material may accept ≤ 10⁵ CFU/g depending on regional feed hygiene regulation. Salmonella is controlled by ISO 6579-1:2017 absence in 25 g for both grades, but the veterinary API additionally excludes Enterobacteriaceae in 1 g and limits bile-tolerant gram-negative bacteria. The difference is not cosmetic: endotoxin release after gram-negative cell rupture can remain even if plate counts fall after heat treatment, and this is only controlled in the veterinary API specification. Heavy metal, dioxin, and polychlorinated biphenyl limits are also tighter in veterinary-grade material because of extended withdrawal-period calculations for food-producing animals. Documentation for veterinary API use normally includes batch-specific certificates for flock health, viral reduction, residual antibiotics, and spray-dryer cleaning validation; these records are absent or incomplete in feed-grade supply chains.

In tablet and capsule dosage forms, the powder functions as a protein-based wet-granulation binder and as a dispersant in dry blends. A low addition rate of 2–5 % w/w is commonly evaluated in high-shear granulators because heated or high-shear mixing can denature the protein fraction at the impeller tip. Granules produced with an aqueous egg powder dispersion at 20–30 °C are compressed to tablet hardness 60–80 N and friability below 1.0 % when tested according to Ph. Eur. 2.9.7; published data for this specific formulation configuration is limited, so the parameters are for initial formulation screening rather than an approved release specification. Dry blending with coarse API crystals should be avoided if the density difference exceeds 0.25 g/cm³ because spray-dried egg powder has poor flow and a Carr index commonly above 25. For low-dose capsules, the powder is used after milling to D90 ≤ 53 µm and is pre-blended with a fine fraction of the active ingredient before adding coarse excipients. The powder also serves as a capsule filler component when granulated with isomalt or lactose to improve flow; without granulation, die filling can be erratic on automatic capsule machines operating above 30 cycles/min.

Viscosity and Reconstitution Boundaries in Aqueous and Solution Systems

For solution and premix preparations, the powder is reconstituted at 5–10 % w/w solids in potable or purified water under propeller agitation at 200–400 rpm for 10–15 min at 20–30 °C. The resulting dispersion is not a true solution because yolk-derived lipoproteins remain colloidal; the soluble fraction is typically 70–85 g/100 g of total solids depending on drying history and pasteurization intensity. Agglomeration is reduced by pre-wetting with 1 part powder to 2 parts water before further dilution. Foam formation is controlled with medical-grade simethicone or mechanical vacuum deaeration; excessive agitation above 600 rpm can produce stable foam and non-reproducible dose delivery in oral drench solutions. For premix blends with mineral carriers, the powder is absorbed onto silica or calcium carbonate at 5–10 % w/w to prevent oily agglomeration from the yolk lipid fraction. Suspension pH after full hydration is typically 6.8–7.6 at 10 % solids; direct acidification before full hydration can produce aggregated protein and should be avoided. If acidic solution administration is required, the dispersion is first hydrated, then adjusted to pH 4.0–5.5 under slow agitation.

In veterinary powder and premix applications, mixing uniformity is assessed using riboflavin or dye tracers until relative standard deviation is below 2–3 % in the final blend. The product is odour-stable, but oxidative rancidity can develop in the lipid fraction because whole-egg powder contains 35–40 g/100 g fat with unsaturated fatty acids; nitrogen-flushed multilayer packaging with moisture vapour transmission below 1.0 g/m²/day is used for long-term storage. Storage at ≤ 25 °C and ≤ 60 % relative humidity is standard; silica gel desiccants are added for tropical distribution. Under these conditions, the product is used within 24 months of spray drying. Reconstituted product is not held for more than 4 h at room temperature or 24 h at 2–8 °C unless a preservative system is validated. These limits reflect microbial risk in non-sterile oral liquids, not compositional instability.

When the API Is Evaluated for Parenteral or Injection Dosage Forms

Intact whole-egg powder is not injected. The injection-grade claim applies to the egg-derived hydrolysate or ultrafiltered fraction prepared from the powder, not to the whole powder as a dry-fill injection. For parenteral use, the reconstituted powder is hydrolyzed with enzymatic or controlled alkaline processing and filtered through a 0.2 µm sterilizing-grade membrane; the resulting solution is depyrogenated until endotoxin level is ≤ 0.5 EU/mg by Ph. Eur. 2.6.14. Whole-egg powder contains phospholipids and lipoproteins that can form particles above 100 nm; direct intravenous administration would present an unacceptable particulate load. Therefore, the vial specification is applied to the processed fraction: appearance clear to slightly opalescent, bioburden before sterile filtration ≤ 10 CFU/100 mL, and endotoxin as above. The dry powder is not terminally sterilized by autoclaving because steam at 121 °C causes irreversible gelation of egg proteins. Gamma irradiation is not recommended for whole-egg powder because lipid radiolysis can generate off-odour compounds and reduce emulsifying capacity; if irradiation is unavoidable, dose mapping and oxidative stability studies are required.

Thermal Denaturation Limits in Granulation and Tablet Compression

Processing temperature is the principal boundary for the egg protein fraction. Ovalbumin begins to denature near 65 °C in high-moisture systems; dry powder can tolerate short exposure to 60 °C during drying or blending, but wet granules should not exceed 45 °C if binding capacity and solubility are to be retained. Compression generates local heating at the tablet press die, especially at press speeds above 30 rpm on rotary machines; tableting runs at elevated pressures can produce hard, amber spots if the powder contains residual moisture above 4.0 g/100 g. Therefore, pre-drying at 40–45 °C in a vacuum tray dryer or fluid-bed dryer is required when water activity exceeds 0.35. The powder is incompatible with strong oxidizing agents and concentrated mineral acids at pH below 3.0; such conditions cause hydrolysis of the phospholipid fraction and release of free fatty acids. Combining with tannin-containing powders at high humidity can produce insoluble protein-polyphenol complexes and should be avoided in chews and licking blocks. The powder is also unsuitable for high-shear homogenization above 10 000 rpm for more than 15 min when preserving functional viscosity is required, because mechanical heating and interfacial denaturation can reduce emulsifying activity.

For premix and drinking-water solutions, the powder is dispersed through a pre-blend with dextrose or lactose at 1:1 to 1:3 ratio before addition to the final feed or water; this reduces lumping in field mixing equipment. In wet granulation, the binder phase is prepared separately at 20–30 °C and added by spray nozzle, not by dry addition to the granulator bowl. After drying, granule moisture is checked before compression; residual water above 2.5 g/100 g can increase sticking on steel tooling. Blends containing this API should be protected from prolonged exposure above 60 % relative humidity. These operational boundaries—not compositional averages—define the difference between veterinary-grade egg powder and unstandardized egg solids used in animal feed.